TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Clarity Pharmaceuticals Ltd. ( (AU:CU6) ).
Clarity Pharmaceuticals Ltd. has announced that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of September 19, 2025. This change in substantial holding could impact Clarity Pharmaceuticals’ shareholder dynamics and influence its market strategy, as State Street’s withdrawal might alter investor confidence and stakeholder engagement.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,314,538
Technical Sentiment Signal: Buy
Current Market Cap: A$1.34B
Find detailed analytics on CU6 stock on TipRanks’ Stock Analysis page.